| NOM-S group (n = 19) | OP group (n = 8) | NOM-F group (n = 3) | P ††|
---|---|---|---|---|
Age†| 31 (15 – 80) | 28 (21–71) | 63 (37–69) | *0.815 |
Male sex | 11 (58%) | 7 (88%) | 0 | 0.124 |
Comorbidities | 5 (26%) | 2 (25%) | 2 (66.7%) | 0.891 |
RTA | 17 (90%) | 6 (75%) | 3 (100%) | 0.332 |
ISS†| 16 (6 – 41) | 43 (21 – 75) | 29 (14–29) | * <0.001 |
Admission Hct (ED)†| 41 (32 – 46) | 27 (24 – 49) | 40 (39–43) | *0.008 |
SBP >90 mmHg (ED) | 18 (95%) | 1 (13%) | 2 (66.7%) | <0.001 |
PR < 100 (ED) | 15 (79%) | 0 (0%) | 2 (66.7%) | <0.001 |
RBC (IU) (first 24 h)†| 0 (0 – 3) | 6 (0 – 11) | 0 (0–2) | * <0.001 |
Intubation (ED) | 1 (5%) | 4 (50%) | 0 | 0.006 |
Positive FAST | 13 (68%) | 8 (100%) | 3 (100%) | 0.072 |